| The CORE Diabetes Model: projecting long-term clinical outcomes, costs and costeffectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and … AJ Palmer, S Roze, WJ Valentine, ME Minshall, V Foos, FM Lurati, ... Current medical research and opinion 20 (sup1), S5-S26, 2004 | 612 | 2004 |
| Projection of osteoporosis-related fractures and costs in China: 2010–2050 L Si, TM Winzenberg, Q Jiang, M Chen, AJ Palmer Osteoporosis International 26, 1929-1937, 2015 | 467 | 2015 |
| Validation of the CORE Diabetes Model against epidemiological and clinical studies AJ Palmera, S Rozea, WJ Valentinea, ME Minshallb, V Foosa, FM Luratia, ... Current Medical Research and Opinion 20 (sup1), S27-S40, 2004 | 352 | 2004 |
| Unprecedented smoke‐related health burden associated with the 2019–20 bushfires in eastern Australia N Borchers Arriagada, AJ Palmer, DMJS Bowman, GG Morgan, ... Medical Journal of Australia 213 (6), 282-283, 2020 | 291 | 2020 |
| Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting AJ Palmer, S Roze, WJ Valentine, P McEwan Diabetes care 30 (6), 1638, 2007 | 288* | 2007 |
| The relationship between return on investment and quality of study methodology in workplace health promotion programs S Baxter, K Sanderson, AJ Venn, CL Blizzard, AJ Palmer American Journal of Health Promotion 28 (6), 347-363, 2014 | 227 | 2014 |
| Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study P Gaede, WJ Valentine, AJ Palmer, DMD Tucker, M Lammert, HH Parving, ... Diabetes care 31 (8), 1510-1515, 2008 | 189 | 2008 |
| Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in … AJ Palmer, S Roze, WJ Valentine, GA Spinas, JE Shaw, PZ Zimmet Clinical therapeutics 26 (2), 304-321, 2004 | 188 | 2004 |
| Unprecedented health costs of smoke-related PM2.5 from the 2019–20 Australian megafires FH Johnston, N Borchers-Arriagada, GG Morgan, B Jalaludin, AJ Palmer, ... Nature Sustainability 4 (1), 42-47, 2021 | 171 | 2021 |
| Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain JA Ray, WJ Valentine, K Secnik, AK Oglesby, A Cordony, A Gordois, ... Current medical research and opinion 21 (10), 1617-1629, 2005 | 164 | 2005 |
| A systematic review of cost-of-illness studies of multimorbidity L Wang, L Si, F Cocker, AJ Palmer, K Sanderson Applied health economics and health policy 16, 15-29, 2018 | 158 | 2018 |
| Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study MS Cooper, AJ Palmer, MJ Seibel Osteoporosis international 23, 97-107, 2012 | 143 | 2012 |
| Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised … AJ Palmer, K Koppenhagen, B Kirchhof, U Weber, R Bergemann Pathophysiology of Haemostasis and Thrombosis 27 (2), 75-84, 1997 | 136 | 1997 |
| Recent trends in life expectancy for people with type 1 diabetes in Sweden D Petrie, TWC Lung, A Rawshani, AJ Palmer, AM Svensson, B Eliasson, ... Diabetologia 59, 1167-1176, 2016 | 131 | 2016 |
| Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK S Roze, WJ Valentine, KE Zakrzewska, AJ Palmer Diabetic Medicine 22 (9), 1239-1245, 2005 | 130 | 2005 |
| Association between fire smoke fine particulate matter and asthma-related outcomes: Systematic review and meta-analysis NB Arriagada, JA Horsley, AJ Palmer, GG Morgan, R Tham, FH Johnston Environmental research 179, 108777, 2019 | 121 | 2019 |
| Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial D Morton, M Seymour, L Magill, K Handley, J Glasbey, B Glimelius, ... Journal of clinical oncology 41 (8), 1541-1552, 2023 | 118 | 2023 |
| The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective AJ Palmer, C Weiss, PP Sendi, K Neeser, A Brandt, G Singh, H Wenzel, ... Diabetologia 43, 13-26, 2000 | 118 | 2000 |
| A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA AJ Palmer, WJ Valentine, R Chen, N Mehin, S Gabriel, B Bregman, ... Nephrology Dialysis Transplantation 23 (4), 1216-1223, 2008 | 115 | 2008 |
| Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and … AJ Palmer, L Annemans, S Roze, M Lamotte, P Lapuerta, R Chen, ... Diabetes Care 27 (8), 1897-1903, 2004 | 115 | 2004 |
